DB-18

N/A

Report date: 2023/03/26 16:39:12
NME

Base Information

Drug NameDB-18
Drug Alias NameDB-18
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionClk dual-specificity kinase inhibitors
TargetsDual specificity protein kinase CLK
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesChemveda Life Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesChemveda Life Sciences Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A